23 July 2026
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
25 June 2026
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
12 June 2026
Employer health insurance costs may rise in 2027 as US firms shift higher premiums, deductibles and drug expenses onto staff.
30 April 2026
Employer-sponsored health insurance in the United States is losing ground as soaring premiums push workers toward cheaper alternatives.